INSM Competitors & Alternatives
Compare Insmed Inc with similar stocks in the same industry
Biotechnology
INSM
Main Stock$94.60
Tradestie Score
52
Market Cap
$31.13B
Revenue Growth
3.0%
Analyst Upside
+108.2%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BNTX
BioNTech SE American Depositary Share
|
$89.91
|
$24.57B | - | 63 | Compare |
|
NTRA
Natera, Inc. Common Stock
|
$398.88
|
$22.18B | - | 59 | Compare |
|
GMAB
Genmab A/S ADS
|
$39.96
|
$19.56B | 30.8 | 37 | Compare |
|
INCY
Incyte Genomics Inc
|
$116.48
|
$16.93B | 14.9 | 77 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$63.64
|
$15.70B | 33.1 | 44 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.37
|
$15.22B | - | 50 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$242.78
|
$12.36B | 17.6 | 51 | Compare |
|
EXEL
Exelixis Inc
|
$65.22
|
$11.09B | 20.3 | 38 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$37.13
|
$10.76B | - | 54 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$195.34
|
$10.74B | - | 35 | Compare |
More INSM Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry